.NET and Visual Studio Elevation of Privilege Vulnerability
CVE-2023-33127

8.1HIGH

Key Information:

Vendor

Microsoft
Status
.net 6.0
.net 7.0
Microsoft Visual Studio 2022 Version 17.0
Microsoft Visual Studio 2022 Version 17.2
Vendor
CVE Published:
11 July 2023

What is CVE-2023-33127?

This vulnerability in the .NET Framework and Visual Studio can allow an attacker to elevate their privileges, potentially gaining access to sensitive system resources. By exploiting this flaw, a malicious actor could execute arbitrary code with elevated permissions. Users and administrators are urged to apply patches and updates from Microsoft to mitigate the risk associated with this vulnerability.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

.NET 6.0 Unknown 6.0.0 < 6.0.20

.NET 7.0 Unknown 7.0.0 < 7.0.9

Microsoft Visual Studio 2022 version 17.0 Unknown 17.0.0 < 17.0.23

References

https://msrc.microsoft.com/update-guide/vulnerability/CVE...
vendor-advisory

CVSS V3.1

Score:
8.1
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
High
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.